The aim of the present study was to investigate the safety of sperm pre-treatment during the ICSI procedure using a mouse model. Mouse spermatozoa were treated with methyl-b-cyclodextrin, lysolecithin, Triton X-100, and dithiothreitol (DTT), and injected into mouse oocytes. The injected oocytes were monitored for chromosomal integrity and pre-and post-implantation development. The chromosomal integrity of the injected oocytes was impaired by in vitro incubation and chemical antagonism. Particularly in the 60-min DTT group, severe chromosome damage increased. Despite the chromosomal damage, the resultant embryos frequently developed to the blastocyst stage. However, the embryos in the 60-min DTT group had significantly higher chromosomal damage and decreased developmental competence to live fetuses. These results indicate that excessive sperm pre-treatment such as DTT for 60 min generates severe chromosome damage in injected oocytes, and that the damage decreases developmental competence to live fetuses but not to blastocysts.
Introduction
Spermatozoa undergo functional changes upon fertilization. Ejaculated spermatozoa are not yet potentially fertilizable. Their fertilizing capacity is acquired in the female genital tract in a process called sperm capacitation. When spermatozoa reach the fertilization site, the acrosome reaction, the exocytotic release of acrosomal enzymes, takes place due to penetration of the oocyte. Thus, only spermatozoa that have undergone these functional changes can be incorporated into the oocytes. As reviewed in Boerke et al. (2008) , bicarbonate, Ca 2C , and albumin can induce sperm capacitation. Furthermore, capacitated spermatozoa are characterized by the redistribution of sperm membrane proteins, glycolipids, and cholesterol. These redistributions trigger spermatozoan hyperactivation, binding to zona, and the zonainduced acrosome reaction. Especially in realignment of sperm membrane proteins, fusion between the plasma membrane and outer acrosomal membrane and subsequent exocytosis of acrosome enzymes are regulated.
ICSI is characterized by direct/microsurgical introduction (injection) of spermatozoa into the oocytes (Yanagimachi 2005) . The injection procedure allows the spermatozoa to fertilize independent of their motility. However, since injected spermatozoa are selected by an operator using outward criteria, such as progressive motility and morphological normality, it is likely that non-capacitated and acrosome-intact spermatozoa are injected into the oocytes and participate in fertilization events.
It is still unknown whether or not the use of spermatozoa with an unphysiological status (e.g. noncapacitated and intact acrosome) influences embryonic development. The hydrolytic enzymes released from sperm acrosomes induced the morphological deformation of injected mouse oocytes (Morozumi & Yanagimachi 2005) . The compelling demembranization of spermatozoa and in vitro induction of the acrosome reaction by chemicals enhanced embryonic development in vitro (Morozumi et al. 2006) . Tateno & Kamiguchi (2007) proposed that capacitated and acrosome-reacted spermatozoa might lower the incidence of chromosomal aberrations in ICSI embryos. The capacitation and acrosome reaction could be mimicked in vitro by cholesterol efflux with methyl-b-cyclodextrin (MBCD; Choi & Toyoda 1998 , Takeo et al. 2008 ) and destabilizing membrane with lysolecithin (LL; Morozumi & Yanagimachi 2005 , Morozumi et al. 2006 or Triton X-100 (TX; Perry et al. 1999) respectively. Therefore, it may be better to use spermatozoa with an in vitroinduced capacitation and acrosome reaction for ICSI (Roldan 2006 ). On the other hand, in ICSI of domestic animals, sperm pre-treatment such as dithiothreitol (DTT) , which leads to a reduction of the protamine disulfide bond in sperm nuclei, was frequently applied due to low fertilizability of domestic animal spermatozoa in in vitro-matured oocytes (Rho et al. 1998 , Galli et al. 2003 , Ock et al. 2003 , Watanabe & Fukui 2006 , Watanabe et al. 2009 ).
Since the influence of sperm pre-treatment on embryonic and fetal normality is not fully understood, we investigated the chromosome integrity of zygotes and embryos derived from spermatozoa pre-treated with MBCD, LL, TX, and DTT. The safety of these sperm pretreatments on in vitro-produced embryos for pre-and post-implantation production was investigated.
Results

Changes of mouse spermatozoa pre-treated with various chemicals
The effects of sperm pre-treatments were visualized by fluorescent dye (Fig. 1) . Sperm pre-treatment with MBCD decreased the fluorescence intensity of the filipin-labeling sperm membrane cholesterol by 30.3% ( Fig. 1A and B ). The chemicals LL and TX removed almost all (99.5 and 99.2% respectively) of the acrosome membrane ( Fig. 1D ), whereas 92.5% of spermatozoa without pre-treatment had an intact acrosome (Fig. 1C ). Furthermore, DTT reduced the disulfide bond in the sperm head in a time-dependent manner.
The spermatozoa with a disulfide bond-reducing head ( Fig. 1F ) increased to 22.6, 83.7, and 94.9% for 10, 30, and 60 min treatments respectively. On the other hand, the control spermatozoa rarely had a disulfide bondreducing head (0.3%).
Chromosomal integrity of mouse oocytes microinjected with in vitro incubated and pre-treated spermatozoa
The results of the chromosomal analysis of ICSI oocytes with spermatozoa incubated in vitro and pre-treated with the four chemicals are summarized in Table 1 . As shown in Table 1 , the cultivation of epididymal spermatozoa in Hepes-buffered Toyoda-Yokoyama-Hoshi medium (H-TYH) for 60 and 90 min increased (P!0.05) zygotic chromosomal breaks to 30.0 and 34.4% respectively. All pre-treatments of sperm induced zygotic chromosomal breaks of 30.8-83.0%, whereas in the control, which did not receive either incubation or pre-treatment, the percentage of breaks was 13.0% (P!0.05). When spermatozoa were treated with DTT for more than 30 min, chromosomal abnormalities remarkably (P!0.001) increased. Particularly, DTT treatment for 30 min and over generated severe aberrants (0.19-0.34). Within a subgroup in DTT treatment, the highest chromosome aberration rate was 83.0% in the group treated for 60 min. The culture of spermatozoa for 30 min following DTT treatment for 30 min (total 60 min) induced no further chromosomal damage.
In vitro development of mouse eggs fertilized with spermatozoa pre-treated with various chemicals
The majority of oocytes injected with pre-treated spermatozoa fertilized (86.5-97.2%) and developed (96.6-98.6%) to the two-cell stage ( Table 2 ). Furthermore, even though spermatozoa were pre-treated with these chemicals, the injected oocytes frequently developed to the blastocyst stage (70.0-87.5%) with active mitosis. The developmental competence in the oocytes injected with these chemicals was comparable to that of the control. On the other hand, as shown in Table 3 , the chromosomal aberration in spermatozoa pre-treated with DTT for 60 min continued up to the blastocyst stage, significantly different (P!0.01) to the control.
In vivo development of mouse embryos derived from spermatozoa pre-treated with various chemicals
The results of embryonic development during the postimplantation are shown in Table 4 . When the embryos derived from spermatozoa pre-treated with DTT for 60 min were transferred to the surrogate females, 42.7 and 23.7% of the transferred embryos implanted and developed to live fetuses respectively. These values were lower than those of the control group (60.9 and 39.8%: P!0.01). On the other hand, the rates of implants and live fetuses in ICSI embryos derived from spermatozoa treated with LL (76.8 and 60.7%) or DTT for 30 min (75.4 and 60.0%) were higher (P!0.05 and P!0.01) than the control group. Moreover, sperm pre-treatment did not affect the proportion of live fetuses per implant. All live fetuses were normal in morphology regardless of whether or not sperm pre-treatment had been performed. Furthermore, all analyzed fetuses had 40 intact chromosomes (Fig. 2 ).
Discussion
It was believed that sperm pre-treatment was effective for in vitro embryo production, and the beneficence depended on the exposure dose and duration of the chemical used. Although the defective effect of MBCD treatment was attributed to the prolonged incubation in vitro rather than to chemical antagonism (Table 1) , it was clearly demonstrated in the present study that as a whole, all sperm pre-treatments were harmful to the spermatozoa; chemical antagonism or in vitro incubation and both during sperm pre-treatment generated chromosomal breaks. In particular, excessive treatment such as DTT for 60 min produced chromosomally damaged embryos, although embryonic development up to the blastocyst stage was not impaired. Two-cell embryos derived from spermatozoa treated with DTT for 60 min induced a lower development of live fetuses, suggesting that the percentage of blastocyst formation was not a direct indicator of developmental competence of embryos to offspring.
In the present study, the chromosomal aberration of ICSI oocytes derived from spermatozoa without any incubation and pre-treatment (control) was relatively higher (13.0%) compared with some previous studies (5.7-8.3%; Szczygiel & Ward 2002 , Watanabe 2004 , Tateno & Kamiguchi 2007 . In this respect, sperm samples in the present study might have contained Statistical significance compared to control: a P!0.001; b P!0.01; c P!0.05. ‡ Statistical significance, comparing the same letters: A,B,C P!0.001; D,E P!0.01; F P!0.05.
*
The proportions of each aberration type in the total number of zygotes with chromosome aberrations. a number of membrane-damaged spermatozoa, since it is reported that the factor released from the spermatozoa induced DNA nicks (Perez-Crespo et al. 2008) . Nevertheless, ICSI oocytes with incubated or pre-treated spermatozoa have much higher rates of chromosome damage than that of the control group.
The targets of each treatment in the present study were different; cholesterol on sperm plasma membrane for MBCD, sperm plasma membrane per se for LL and TX, and the disulfide bond in sperm nuclei for DTT. Therefore, it was inferred that DTT was the most severe treatment compared with the others. The defective effect on the chromosomal integrity of spermatozoa along with the disulfide bond-reducing ability occurred in a timedependent manner. The under-protaminated spermatozoa are less normal (Bianchi et al. 1993 , Manicardi et al. 1995 , Sakkas et al. 1996 . Thus, DNAs of DTT-treated spermatozoa, lacking a disulfide bond, are breakable. Since DTT destroys the sperm plasma membrane depending on the duration of treatment (Ock et al. 2003) , excessive treatment of DTT (such as 60 min) would be harmful to sperm chromosomes. In turn, there is supporting evidence that prolonged DTT treatment (50-60 min; Yong et al. 2005 , Watanabe & Fukui 2006 and a combination of TX and DTT treatments (Nakai et al. 2006 ) degrade the fertilizability and developmental competence of porcine oocytes. Additionally, DTT treatment with a lower dose (2 mM) and for a shorter period (15 min) does not generate chromosomal nicks (Szczygiel & Ward 2002) . The outcomes in Table 1 also show that prolonged exposure (60 min) to DTT increased chromosomal breaks, while DTTCculture for 30 min each induced no further damage compared with the 30-min DTT group.
Medium components (Hepes, ion balance, and others) affect sperm chromosome integrity (Tateno et al. 2000 , Watanabe 2004 , Tateno & Kamiguchi 2007 . Changes in the sperm membrane induced by pre-treatment might be one of the reasons for the induction of chromosomal lesions due to direct exposure to medium components. As described above, most chromosomal lesions by MBCD treatment are caused by in vitro incubation for 90 min. These findings suggest that a shorter treatment is needed for chromosomal integrity in spermatozoa. However, it should be noted that LL and TX treatments were performed for only 1 min and increased chromosomal breaks. It was noteworthy that the spermatozoa were damaged within only a few minutes (w5 min) between individual demembranization of the spermatozoon and injection into oocytes. Since chromosomal damage of membrane-disrupted spermatozoa by freezedrying was decreased by modifying the pH value of storage media (Kaneko et al. 2003b) , and by pre-treating with diamide (Kaneko et al. 2003a ) and EGTA (Kusakabe et al. 2008) , the optimization of conditions during sperm pre-treatment might reduce chromosomal damage. Sperm DNA provides half of an embryo's genetic source. Therefore, chromosomal damage of spermatozoa might induce defective zygotic gene activation that begins at the middle of the one-cell stage and bursts into the two-cell stage (Minami et al. 2007) . Therefore, detailed observation of embryos derived from pre-treated spermatozoa should be carried out during pre-and post-implantation. The present results revealed that embryos derived from damaged (pre-treated) spermatozoa frequently developed up to the blastocyst stage with active mitosis (Table 2) , in agreement with another study (Perez-Crespo et al. 2008 ). However, DNA-damaged spermatozoa reduced blastocyst formation depending on the disintegration level (Ahmadi & Ng 1999a , 1999b . These observations might suggest that the types of chromosomal damage generated in our study were insignificant for embryonic development during the pre-implantation stage. However, there was a contradiction between the percentage of blastocyst formation and that of chromosomal aberration of the blastocysts: the percentage of chromosomal aberration in DTT for 60 min was higher (66.7%; Table 3 ). In consequence, post-implantation development of the embryos in DTT treatment for 60 min was impaired, in agreement with previous studies (Montag et al. 1997 , Stern et al. 1999 , Benchaib et al. 2003 , Tateno & Kamiguchi 2007 , where it was shown that zygotic/ embryonic chromosomal damage was a serious problem in ongoing pregnancy. These facts clearly demonstrate that a competent embryo is the result of chromosomal integrity -not developmental capacity -up to the blastocyst stage.
Previous studies demonstrated that DNA doublestrand breaks were restored (Kanaar et al. 1998) , and that oocytes were capable of repairing sperm DNA lesions until the first mitotic division (Generoso et al. 1979 , Genescà et al. 1992 or during subsequent embryonic development (Generoso et al. 1979 , Ahmadi & Ng 1999b . Therefore, from the results in Table 3 , it was possible to interpret that embryos derived from spermatozoa treated with MBCD, LL, or TX were restored during embryonic development, while the damage generated by DTT for 60 min was beyond the repair potential of oocytes. The number of chromosomal aberrations per ICSI oocyte injected with spermatozoa pre-treated with these chemicals (0.46-5.36; Table 1 ) may support this interpretation. In other words, 'minor' chromosome damage in zygotes is repairable during the pre-and post-implantation stages. For example, the minor chromosome aberration in ICSI oocytes of the 60-min DTT group was 66% (Table 1) , and some of these aberrations could be repaired. Therefore, the percentage of fetuses that could be obtained was 20% or more, although the incidence of chromosomal damage in ICSI oocytes was higher (83.0%). On the other hand, the severe chromosome aberration in ICSI oocytes in the 30-and 60-min DTT groups might have resulted in the wide range in the rates of live fetuses.
Post-implantation development of ICSI embryos derived from pre-treated spermatozoa was thus acceptable, except in the 60-min DTT treatment group. As reported previously (Morozumi et al. 2006) , ICSI embryos derived from LL-treated spermatozoa had higher developmental competence in the postimplantation stage, suggesting that the acrosomal contents might hinder embryonic development in this phase. Interestingly, a higher developmental competence was also observed in DTT treatment for 30 min in the present study. However, it was not clear from the results how this higher developmental competence occurred. It might have been induced by the reducing disulfide bond and membrane disruption (Ock et al. 2003) in DTT treatment. Nevertheless, the appropriate duration of DTT treatment is likely !30 min, as supported by our previous study in pig (Watanabe & Fukui 2006) .
The present results provide an additional possibility that the previous application of sperm pre-treatment into bull (Galli et al. 2003 ) and boar (Watanabe & Fukui 2006 , Watanabe et al. 2009 ) spermatozoa might have induced critical damage in their chromosomes, since the success of sperm pre-treatment was decided only by monitoring embryonic development up to the blastocyst stage. In livestock, however, sperm pretreatment during ICSI procedures would be very advantageous due to low fertilizability of the oocytes in these animals. Our goal is to establish the most appropriate method of sperm pre-treatment in order to improve the production of normal embryos and offspring mediated by ICSI.
In conclusion, in vitro incubation and chemical antagonism during sperm pre-treatments induced chromosomal aberrations in ICSI oocytes. Despite the chromosomal damage, the resultant embryos developed to the blastocyst stage. However, the ICSI oocytes derived from spermatozoa pre-treated with DTT for 60 min contained massive chromosome aberrations and decreased embryonic development during post-implantation. Thus, the present sperm pre-treatment before ICSI was not always effective, and fetal development was not in line with blastocyst development. Given these issues, the use of sperm pre-treatment for the ICSI procedure needs to be reconsidered.
Materials and Methods
Reagents and media
All chemicals were purchased from Wako Pure Chemical Industries Ltd (Osaka, Japan) unless otherwise stated. The culture medium used for the mouse oocytes after ICSI was Chatot-Ziomek-Bavister (CZB; Chatot et al. 1989 ) supplemented with 5.56 mM D-glucose and 4 mg/ml BSA (fraction V; Sigma-Aldrich). Mouse oocyte collection and microinjection were performed in modified CZB supplemented with 20 mM Hepes-Na, 5 mM NaHCO 3 , and 0.1 mg/ml polyvinyl alcohol (cold water soluble; Sigma-Aldrich) in place of BSA (H-CZB). Mouse spermatozoa were collected in a modified TYH medium (Toyoda et al. 1971) supplemented with 20 mM Hepes, 5 mM NaHCO 3 , and 0.1 mg/ml polyvinyl alcohol in place of BSA (H-TYH). The pH value of both H-CZB and H-TYH was adjusted to w7.4. The chemicals (MBCD, LL, TX, and DTT) for sperm pre-treatment were from Sigma-Aldrich. For culture of skin cells derived from fetuses, DMEM (Sigma-Aldrich) supplemented with 1% penicillin-streptomycin solution (Sigma-Aldrich) and 10% FCS (Gibco-BRL) was used.
Animals
All animals were purchased from CLEA Japan, Inc (Tokyo, Japan). The oocytes and spermatozoa were collected from B6D2F1 mice. ICR mice were used as surrogate mothers. All experiments were performed according to the Guiding Principles for the Care and Use of Research Animals of Obihiro University of Agriculture and Veterinary Medicine.
Preparation of oocytes and spermatozoa for ICSI B6D2F1 female mice, 7-11 weeks of age, were superovulated by i.p. injection of 10 IU eCG (Asuka Pharmaceutical, Tokyo, Japan) followed by injection of 10 IU hCG (Asuka Pharmaceutical) 48 h later. The oocytes recovered from oviducts between 14 and 16 h after hCG injection were denuded of their cumulus cells by treatment with 0.1% (w/v) bovine testicular hyaluronidase (Sigma-Aldrich) in H-CZB. The denuded oocytes were repeatedly rinsed in CZB medium and kept at 37 8C under 5% CO 2 in the same medium until ICSI. Spermatozoa were collected from the cauda epididymis of 7-12-week-old male mice. The collected spermatozoa were immediately used for the experiments.
Sperm pre-treatment
In MBCD treatment, the spermatozoa were kept in H-TYH containing 0.75 mM MBCD for 90 min (Choi & Toyoda 1998) at 37 8C. The treated spermatozoa were washed twice by centrifugation at 300 g for 5 min in H-TYH. A small amount (1-2 ml) of the sperm suspension was transferred into a droplet (5 ml) of H-TYH containing 10-12% polyvinyl pyrrolidone (PVP; molecular weight: 360 000; Nacalai Tesque, Kyoto, Japan). Motile spermatozoa were collected and used for ICSI. The sperm pre-treatment procedure followed that done in a previous study (Morozumi et al. 2006) . Namely, a motile spermatozoon was collected by a micromanipulator under an inverted microscope and transferred into the droplets of H-TYH containing 0.02% of LL, 0.02% of TX, or 5 mM DTT. After treatment, the spermatozoa were recovered and washed twice in a fresh H-TYH droplet with PVP. The duration of each treatment was 1 min (LL and TX) and 10, 30, or 60 min (DTT).
ICSI procedures
As the control, motile spermatozoa without any treatment and cultivation were used for ICSI. Before injection, a batch of 15 oocytes was transferred into a droplet (5 ml) of H-CZB, which had been beside a sperm-containing droplet in an ICSI chamber covered with paraffin oil (Merck). A control or treated spermatozoon was aspirated into the injection pipette tail first, and the tail was cut at the mid-piece by applying several piezo pulses. The tail-cut spermatozoon was then individually injected into a mouse oocyte according to the method of Kimura & Yanagimachi (1995) . The series of experiments for ICSI were completed within 30 min of sperm pre-treatment.
Culture of oocytes injected with spermatozoa
The injected oocytes were washed with CZB and cultured in a droplet (30 ml) of the same medium covered with paraffin oil at 37 8C under 5% CO 2 in air. The oocytes that had a second polar body and two pronuclei after 5-6 h of ICSI were considered to be normally fertilized. The developmental stage of the embryos was observed at 24 and 96 h after ICSI.
Chromosome preparation of fertilized eggs and blastocysts
After 6-8 h of ICSI, the oocytes were transferred to CZB containing 0.02 mg/ml vinblastine sulfate to inhibit the first cleavage division. At 19-21 h after ICSI, they were treated with 0.5% protease (Kaken Pharmaceuticals, Tokyo, Japan) in Ca 2Cand Mg 2C -free Dulbecco's PBS to digest zona pellucida. They were then kept in a solution consisting of equal volumes of 1% (w/v) sodium citrate and 30% (v/v) FCS (hypotonic solution) for 10 min at room temperature. These samples were prepared by the gradual fixation/air drying method (Mikamo & Kamiguchi 1983) . The slides were stained with 2% Giemsa (Merck) in buffered saline (pH 6.8) for 10 min. Chromosomal aberrations were then examined without distinguishing between paternal and maternal nuclei. The detected aberrations were judged as paternal in origin because mouse oocytes rarely have chromosomal aberrations (Tateno & Kamiguchi 2002) . Furthermore, the metaphase plates were classified as normal (Fig. 3A) , minor (1-9 chromosome breaks in a metaphase plate; Fig. 3B ) and severely (more than ten chromosome breaks in a metaphase plate; Fig. 3C ) aberrant as reported by Kaneko & Nakagata (2005) .
After culture for 96 h, the developed blastocysts were incubated in CZB containing 0.04 mg/ml colcemid (Sigma-Aldrich) for 3 h and were treated with 0.5% protease followed by a hypotonic solution for 2-3 min. Thereafter, the embryos were fixed and stained as described above. The number of cells was counted, and the mitotic index, an indicator of cell growth, was defined as the ratio between the number of mitotic and total number of cells (McCauley et al. 2003) . Intact and nonoverlapping chromosome spreads (range: 1-8 cells in an embryo) were examined for analysis. In the present study, an embryo containing cell(s) with structural aberration and/or abnormal ploidy (haploid, mixoploid, and polyploid) was judged as aberrant ( Fig. 4) .
Examination of post-implantation development and fetal chromosome analysis
Two-cell embryos were transferred into the oviducts of ICR pseudopregnant females at 8-14 weeks of age. Recipients were killed on day 16 of pregnancy, and the number of implantation sites and live fetuses were recorded. Live fetuses were randomly selected for examination of their chromosome integrity. After the fetal skin cells were cultured for 3-5 days under 5% CO 2 in air at 37 8C, they were treated with 0.05 mg/ml colcemid for 2-3 h. The cells recovered by treating trypsin-EDTA solution (Gibco-BRL) were kept in 0.075 M KCl in distilled water. They were then fixed with a methanol-acetic acid (3:1) mixture on a glass slide. The G-banded chromosome slides were obtained by a routine trypsin digestion method. The karyotype was determined according to previous reports (Nesbitt & Francke 1973 , Cowell 1984 ).
Visualization of the effects of sperm pre-treatments
Functional changes of pre-treated spermatozoa (at least 100 cells in each group) were monitored by fluorescent dye as described below.
Sperm membrane cholesterol of the MBCD-treated spermatozoa was labeled with 0.1 mg/ml filipin (Cayman Chemical, Ann Arbor, MI, USA) for 30 min at room temperature in the dark. The spermatozoa were then smeared on glass slides and examined by fluorescence (UV excitation filter: UV-2A, Nikon, Tokyo, Japan). The fluorescence intensity was quantified using Image J software (National Institutes of Health, Bethesda, MD, USA; http://rsb.info.nih.gov/ij/). Spermatozoa pre-treated with LL and TX were mixed in 95% ethanol and kept for 30 min at 4 8C. Thereafter, the spermatozoa were smeared and the sperm acrosomes stained by 0.1 mg/ml FITC-PNA (Vector Laboratories, Inc., Burlingame, CA, USA) for 10 min at room temperature in the dark. The samples were sealed by Vectashield Mounting Medium with DAPI (Vector Laboratories, Inc.) and examined by fluorescence (B excitation filter: B-2A, Nikon).
Spermatozoa pre-treated with DTT were smeared on glass slides and fixed in a methanol-acetic acid (3:1) mixture. After fixation, the slides were stained with 0.2% acridine orange (Sigma-Aldrich) for 5 min at room temperature and examined by fluorescence (B excitation filter).
Statistical analysis
All experiments were repeated for 3-5 times. The c 2 or Fisher's exact probability test was used for analyses of the rates of chromosomal aberration and developmental competence. 
